Is a
Clinical Study attributes
NCT Number
Trial Recruitment Size
590
Trial Sponsor
Clinical Trial Start Date
2015
0Primary Completion Date
December 6, 2019
0Study Completion Date
December 6, 2019
0Clinical Trial Study Type
Observational0
Intervention Type
Genetic0
Intervention Name
Allo-HSCT0
Observational Clinical Trial Type
Cohort0
Observational Study Perspective
Other0
Participating Facility
Official Name
A Prospective and Retrospective Data Collection Study to Evaluate Outcomes in Males ≤17 Years of Age Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Cerebral Adrenoleukodystrophy0
Last Updated
May 21, 2020
0Study summary
Study ALD-103 will be a multi-site, global, prospective and retrospective data collection study that is designed to evaluate outcomes of allo-HSCT in male subjects with CALD ≤17 years of age.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
